Skip to main content
. 2021 Feb 18;11(2):304. doi: 10.3390/biom11020304

Figure 5.

Figure 5

Similar to breast cancer, anti-tumor compounds and lncRNAs can regulate the miRNA/PTEN axis in affecting the progression of lung cancer cells.